0001415889-24-022000.txt : 20240822
0001415889-24-022000.hdr.sgml : 20240822
20240822160740
ACCESSION NUMBER: 0001415889-24-022000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240820
FILED AS OF DATE: 20240822
DATE AS OF CHANGE: 20240822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Donald Allen
CENTRAL INDEX KEY: 0001620013
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 241232062
MAIL ADDRESS:
STREET 1: C/O PRYOR CASHMAN LLP
STREET 2: 7 TIMES SQUARE
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (310) 618-6994
MAIL ADDRESS:
STREET 1: 3060 PEGASUS PARK DRIVE
STREET 2: BUILDING 6
CITY: DALLAS
STATE: TX
ZIP: 75247
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
form4-08222024_080837.xml
X0508
4
2024-08-20
0001419041
Forte Biosciences, Inc.
FBRX
0001620013
Williams Donald Allen
C/O FORTE BIOSCIENCES, INC.
3060 PEGASUS PARK DR., BUILDING 6
DALLAS
TX
75247
true
false
false
false
0
Stock Option (right to buy)
0.344
2024-08-20
4
A
0
50000
0
A
2034-08-20
Common Stock
50000
50000
D
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean August 20, 2024.
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2024-08-22